Indiana § 25-1-9-6.8 Practitioner guidelines before prescribing stimulant medication for a
child for treatment of certain disorders

Indiana Statutes

§ 25-1-9-6.8 — Practitioner guidelines before prescribing stimulant medication for a child for treatment of certain disorders

Indiana § 25-1-9-6.8

Title 25PROFESSIONS AND OCCUPATIONS

Art. 1GENERAL PROVISIONS

Ch. 9Health Professions Standards of Practice

This text of Indiana § 25-1-9-6.8 (Practitioner guidelines before prescribing stimulant medication for a child for treatment of certain disorders) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 25-1-9-6.8 (2026).

Text

8.

(a)This section applies to a practitioner who is:

(1)licensed to practice medicine or osteopathic medicine under IC 25-22.5; or

(2)an advanced practice registered nurse granted prescriptive authority under IC 25-23 and whose practice agreement with a collaborating physician reflects the conditions specified in subsection (b).

(b)Before prescribing a stimulant medication for a child for the treatment of attention deficit disorder or attention deficit hyperactivity disorder, a practitioner described in subsection (a) shall follow the most recent guidelines adopted by the American Academy of Pediatrics or the American Academy of Child and Adolescent Psychiatry for the diagnosis and evaluation of a child with attention deficit disorder or attention deficit hyperactivity disorder.

Free access — add to your briefcase to read the full text and ask questions with AI

8. (a) This section applies to a practitioner who
is:
(1) licensed to practice medicine or osteopathic medicine under
IC 25-22.5; or
(2) an advanced practice registered nurse granted prescriptive
authority under IC 25-23 and whose practice agreement with a
collaborating physician reflects the conditions specified in
subsection (b).
(b) Before prescribing a stimulant medication for a child for the
treatment of attention deficit disorder or attention deficit hyperactivity
disorder, a practitioner described in subsection (a) shall follow the most
recent guidelines adopted by the American Academy of Pediatrics or
the American Academy of Child and Adolescent Psychiatry for the
diagnosis and evaluation of a child with attention deficit disorder or
attention deficit hyperactivity disorder.